![]() |
市場調查報告書
商品編碼
1960009
矽膠泡棉敷料市場-全球產業規模、佔有率、趨勢、機會、預測:按產品類型、應用、最終用戶、地區和競爭對手分類,2021-2031年Silicone Foam Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球矽膠泡棉敷料市場預計將從 2025 年的 15.8 億美元成長到 2031 年的 21.1 億美元,複合年成長率為 4.94%。
這些可吸收的多層醫療設備採用柔軟的矽膠接觸層來管理傷口滲出液,同時最大限度地減少移除過程中的疼痛和組織損傷。推動這一市場成長的主要因素是慢性傷口(例如糖尿病足潰瘍和壓瘡)在全球範圍內的日益普遍。這些傷口需要有效的長期照護方案,而人口老化導致皮膚脆弱、癒合延遲,進一步加劇了這項需求。正如國際糖尿病聯盟(IDF)在2024年指出的那樣,全球約有5.89億成年人患有糖尿病,凸顯了開發先進的傷口管理產品以應對相關併發症的迫切需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 15.8億美元 |
| 市場規模:2031年 | 21.1億美元 |
| 複合年成長率:2026-2031年 | 4.94% |
| 成長最快的細分市場 | 慢性傷口 |
| 最大的市場 | 北美洲 |
儘管這些特殊敷料具有明顯的臨床優勢,但與傳統紗布產品相比,其高昂的價格已成為市場推廣的一大障礙。這種價格差異限制了其廣泛應用,尤其是在醫療預算有限的發展中地區,這些地區往往優先考慮採購量而非先進技術。此外,國際上缺乏統一的報銷政策也阻礙了將矽膠泡棉敷料納入標準治療通訊協定。因此,許多醫療機構被迫依賴價格更低、療效較差的替代方案,限制了先進矽膠泡沫療法的廣泛應用。
慢性傷口,尤其是糖尿病足潰瘍的發生率不斷上升,是全球矽膠泡棉敷料市場的主要驅動力。隨著糖尿病患者數量的增加,對能夠有效控制大量滲出液並防止浸漬的敷料的需求日益成長,而矽膠泡棉敷料因其能夠維持濕潤環境而備受青睞。近期產業趨勢也印證了這項強勁的臨床需求。例如,科樂普公司在2024年11月報告稱,其先進創傷護理業務在2023/24會計年度實現了10%的內部成長,主要得益於慢性病護理領域的強勁發展勢頭。這一成長表明,慢性皮膚病負擔的加重與市場商業性擴張之間存在直接關聯。
同時,全球外科手術數量的不斷成長推動了相關技術的應用,尤其是在術後切口管理方面,旨在降低感染風險並最大限度地減少疤痕。這一趨勢正促使人們從傳統的紗布轉向非侵入性的矽膠泡沫解決方案。美國癌症協會 (ACS) 的統計數據也印證了外科手術量與創傷護理需求之間的相關性。該協會在 2024 年 1 月預測,美國新增癌症病例將超過 200 萬例,這將導致手術需求的大幅增加。為了滿足這項需求,Molnlycke 公司於 2024 年 3 月宣布,其 2023 會計年度的年度淨銷售額達到創紀錄的 19.24 億歐元。這一業績歸功於其專注於外科手術和創傷護理解決方案的策略策略。
矽膠泡棉敷料的高昂購置成本構成了市場擴張的重大經濟障礙,尤其是在醫療基礎設施成本敏感的地區。儘管這些先進敷料在治療慢性傷口方面具有卓越的臨床療效,但與傳統紗布相比,其高昂的價格迫使採購部門優先考慮即時預算削減,而非長期療效。此外,健保報銷政策的不一致也加劇了這種財務壓力,因為這些政策往往無法涵蓋先進創傷護理產品的高昂成本。因此,醫療機構常常被迫使用療效較差但成本更低的替代品,這實際上抑制了資金緊張的發展中市場和成熟市場的收入成長。
這些預算限制在醫療資金分配給醫療設備體現得淋漓盡致。根據歐洲醫療技術協會(MedTech Europe)2024年的數據,包括耗材創傷護理設備在內的醫療技術支出約佔歐洲醫療總支出的7.9%。這種有限的分配凸顯了特種矽膠敷料在資金競爭方面面臨的嚴峻挑戰。儘管慢性傷口數量的增加帶來了明顯的臨床需求,但這些資金限制阻礙了先進的矽膠解決方案在標準治療通訊協定中取代價格較低的傳統產品。
市場正經歷著一場根本性的轉變,即從被動治療轉向主動降低風險,從而將矽膠泡棉敷料用於預防壓瘡。醫療機構正擴大將符合人體解剖結構的矽膠泡棉敷料納入高風險手術和重症監護患者的標準通訊協定中,以重新分配壓力並減少剪切力。這種臨床轉變正成為製造商重要的收入來源。例如,史密斯醫療(Smith & Nephew)在2024年2月發布的報告顯示,其高階傷口管理部門2023年的核心收入成長了6.4%,反映出市場對感染控制和壓力管理產品線的持續需求。這一趨勢表明,預防性技術在急診環境中的價值日益凸顯。
同時,居家照護模式的普及速度顯著加快,對適用於非臨床環境的傷口管理解決方案的需求也隨之成長。隨著醫療系統致力於降低再入院率和醫療成本,對於居家治療慢性潰瘍的患者而言,能夠延長佩戴時間且易於使用的矽膠泡棉敷料的需求日益成長。這種向分散式護理模式的轉變正在推動該領域的內部成長。 2024年3月,康維特集團宣布,其高級創傷護理部門2023年的自然銷售額成長了9.5%,並將這一業績歸功於慢性病護理解決方案的強勁需求。這一成長軌跡凸顯了便捷易用的醫療設備在支持全球轉變為以社區為中心的醫療服務模式過程中所扮演的重要角色。
The Global Silicone Foam Dressings Market is projected to expand from USD 1.58 Billion in 2025 to USD 2.11 Billion by 2031, registering a CAGR of 4.94%. These absorbent, multi-layered medical devices utilize a soft silicone contact layer to manage wound exudate while minimizing pain and tissue trauma during removal. A primary factor fueling this growth is the increasing global prevalence of chronic wounds, such as diabetic foot ulcers and pressure injuries, which demand effective long-term care solutions. This need is further intensified by an aging global population that is prone to skin fragility and slower healing. As noted by the International Diabetes Federation in 2024, nearly 589 million adults globally were living with diabetes, highlighting the urgent necessity for advanced wound management products to address associated complications.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.58 Billion |
| Market Size 2031 | USD 2.11 Billion |
| CAGR 2026-2031 | 4.94% |
| Fastest Growing Segment | Chronic Wounds |
| Largest Market | North America |
Despite the clear clinical advantages, the market encounters significant obstacles due to the high acquisition costs of these specialized dressings compared to traditional gauze options. This price disparity restricts widespread adoption, particularly in developing regions with limited healthcare budgets where procurement often prioritizes volume over advanced technology. Additionally, inconsistent reimbursement policies across various international territories create financial hurdles that impede the integration of silicone foam solutions into standard treatment protocols. Consequently, many healthcare providers are forced to rely on less expensive and less effective alternatives, limiting the potential reach of advanced silicone foam therapies.
Market Driver
The escalating prevalence of chronic wounds, particularly diabetic foot ulcers, acts as the primary catalyst driving the global silicone foam dressings market. As the diabetic population grows, there is an intensified need for dressings that can manage high levels of exudate while preventing maceration, with silicone foam being preferred for its ability to maintain a moist healing environment. This strong clinical demand is evident in recent industry performance; for instance, Coloplast reported in November 2024 that their Advanced Wound Care business achieved 10% organic growth for the 2023/24 financial year, a rise largely fueled by momentum in the chronic care sector. This growth illustrates the direct link between the rising burden of chronic skin conditions and the commercial expansion of the market.
Simultaneously, the increasing volume of surgical procedures worldwide is boosting adoption, specifically for postoperative incision management aimed at reducing infection risks and minimizing scarring. This trend is driving a shift from traditional gauze to atraumatic silicone foam solutions. The correlation between surgical activity and wound care demand is supported by statistics from the American Cancer Society, which projected in January 2024 that new cancer cases in the US would exceed 2 million, necessitating a higher number of surgeries. Reflecting this demand, Molnlycke announced in March 2024 that it achieved record annual net sales of EUR 1,924 million in 2023, a performance attributed to its strategic focus on surgical and wound care solutions.
Market Challenge
The substantial acquisition cost of silicone foam dressings presents a significant economic barrier that hinders market expansion, especially in regions with cost-sensitive healthcare infrastructures. Although these advanced dressings provide superior clinical outcomes for chronic wounds, their premium pricing compared to traditional gauze often compels procurement departments to favor immediate budget savings over long-term efficacy. This financial pressure is compounded by inconsistent reimbursement policies that frequently fail to cover the higher costs of advanced wound care products. As a result, healthcare providers are often left with little choice but to utilize less effective, lower-cost alternatives, effectively capping revenue growth in both developing and established markets facing fiscal constraints.
This budgetary strain is clearly reflected in the allocation of healthcare funds for medical devices. According to MedTech Europe data from 2024, expenditure on medical technologies-including consumable wound care devices-averaged approximately 7.9% of total healthcare spending across European systems. This restrictive allocation emphasizes the intense competition for financial resources that specialized silicone dressings face. Despite the clear clinical necessity driven by the rising prevalence of chronic wounds, these financial limitations hamper the ability of advanced silicone solutions to displace cheaper traditional options within standard care protocols.
Market Trends
The market is witnessing a fundamental shift toward the prophylactic use of silicone foam dressings for pressure injury prevention, moving the focus from reactive treatment to proactive risk mitigation. Healthcare institutions are increasingly incorporating anatomically contoured silicone foams into standard protocols for at-risk surgical and ICU patients to redistribute pressure and reduce shear forces. This clinical pivot is becoming a vital revenue source for manufacturers. For example, Smith+Nephew reported in February 2024 that their Advanced Wound Management unit delivered 6.4% underlying revenue growth in 2023, reflecting sustained demand for infection control and pressure management portfolios. This trend highlights the growing value placed on preventative technologies in acute care settings.
Concurrently, there is a distinct acceleration in the adoption of home-based care models, which drives the need for wound management solutions suitable for non-clinical environments. As healthcare systems seek to lower hospital readmissions and costs, there is rising demand for silicone foam dressings that offer extended wear times and ease of application for patients managing chronic ulcers at home. This move toward decentralized treatment is fueling organic expansion in the sector. Convatec Group Plc noted in March 2024 that their Advanced Wound Care category achieved 9.5% organic revenue growth in 2023, a performance attributed to the strong adoption of their chronic care solutions. This trajectory underscores the critical role of user-friendly devices in supporting the global shift toward community-centered health delivery.
Report Scope
In this report, the Global Silicone Foam Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Silicone Foam Dressings Market.
Global Silicone Foam Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: